Interleukin-1 blockers: A new class of nonarachidonate, nonsteroidal antiinflammatory drugs

Drugs of the Future

Volumn 24, Issue 9, 1999, Pages 979-990

  Chiou, George C Y ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ANILINO 3 PHENYL 1,3 THIAZINE; 3,4 DIMETHYL 9(10H) ACRIDONE; 4,6 DIHYDROXYPYRIDAZINO[4,5 C]PYRIDAZINE 5(1H) ONE; 5 BROMOTETRAHYDRO 5 METHYL 3 PHENYL 2 PHENYL 2 PHENYLIMINO 4H 1,3 THIAZINONE; FLUOROURACIL; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; MITOMYCIN C; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG CONFORMATION; DRUG EFFECT; DRUG POTENCY; DRUG SYNTHESIS; EYE IRRITATION; GASTROINTESTINAL HEMORRHAGE; GLAUCOMA; HUMAN; POSTOPERATIVE COMPLICATION; REVIEW; STRUCTURE ACTIVITY RELATION; TRABECULECTOMY; TREATMENT INDICATION; UVEITIS;

EID: 0032743713     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1999.024.09.858628     Document Type: Review

References (93)

1. Schimmer, B.P., Parker, K.L. ACTH: Adrenocortical steroids and their synthetic analogs: Inhibitors of the synthesis and actions of adrenocortical hormones. In: The Pharmacological Basis of Therapeutics, 9th Ed. Hardman, J.G. et al. (Eds.). McGraw-Hill: New York 1996, 1459-85.
2. Masuda, K. Anti-inflammatory agents: Non-steroidal anti-inflammatory drugs. In: Pharmacology of the Eye. Sears, M.L. (Ed.). Springer-Verlag: New York 1984, 539-51.
3. Lombardino, J.G. Non-steroidal Anti-inflammatoxy Drugs. John Wiley & Sons: New York 1985.
4. Piper, P.J. The Leukotrienes: Their Biological Significance. Raven Press: New York 1986.
5. Braquet, P. Handbook of PAF and PAF Antagonists. CRC Press: Boca Raton 1991.
6. Kimball, E.S. Cytokines and Inflammation. CRC Press: Boca Raton 1991.
7. Chiou, G.C.Y., Yao, Q.S., Chang, M.S., Okawara, T. Prevention and treatment of ocular inflammation with a new class of non-steroidal antiinflammatory agent. J Ocul Pharmacol Ther 1994, 10: 335-47.
8. Chiou, G.G.Y, Yao, Q.S., Okawara, T. Prevention of ocular inflammation induced by lens protein, endotoxin, and interleukin-1 with synthetic interleukin-1 blockers. J Ocul Pharmacol Ther 1994, 10: 577-86.
9. Dawson, M.M. Lymphokines and Interleukins. CRC Press: Boca Raton 1991.
10. Chiou, G.C.Y., Liu, S.X.L. Novel non-arachidonate-mediated, non-steroidal antiinflammatory agents. Exp Opin Invest Drugs 1994, 3: 725-32.
11. Chiou, G.C.Y., Liu, S.X.L. Novel non-traditional non-steroidal antiinflammatory agents. Exp Opin Ther Patents 1996, 6: 41-56.
12. Chan, L.S., Hammerberg, C., Kang, K., Sabb, P., Tavakkol, A., Cooper, K.D. Human dermal fibroblast interleukin-1 receptor antagonist (IL-1ra) and interieukin-1β (IL-1β) mRNA and protein are co-stimulated by phorbol ester: Implication for a homeostatic mechanism. J Invest Dermatol 1992, 99: 315-22.
13. Andersson, J., Bjork, L., Dinarello, C.A., Towkin, H., Andersson, U. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol 1992, 22: 2617-23.
14. Zamir, O., Hassdgren, P.O., O'Brien, N., Thompson, R.C., Fischer, J.E. Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra). Ann Surg 1992, 216: 381-7.
15. Van der Poll, T., Van Deventer, S.J., ten Cate, H., Levi, M., ten Cate, J.W. Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia. J Infect Dis 1994, 169: 665-7.
16. Ulich, T.R., Quo, K., Yin, S. et al. Endotoxin induced cytokine gene expression in vivo. IV. Expression of interleukin-1 α/β and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. Am J Pathol 1992, 141: 61-8.
17. Romero, R., Sepulveda, W., Mazor, M. et al. The natural interleukin-1 receptor antagonist in term and preterm parturition. Am J Obstet Gynecol 1992, 167: 863-72.
18. Romero, R., Tartakovsky, B. The natural interleukin-1 receptor antagonist prevents interleukin-1 preterm delivery in mice. Am J Obstet Gynecol 1992, 167: 1041-5.
19. Koch, A.E., Kunkel, S.L., Chensue, S.W., Haines, G.K., Strieteo, R.M. Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages. Clin Immunol Immunopathol 1992, 5: 23-9.
20. Petitclerc, E., Abel, S., deBlois, D., Poubelle, P.E., Marceau, F. Effects of interleukin-1 receptor antagonist on three types of responses to interleukin-1 in rabbit isolated blood vessels. J Cardiovasc Pharmacol 1992, 19: 821-9.
21. Bluthe, R.M., Dantzer, R., Kelley, K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rats. Brain Res 1992, 573: 318-20.
22. DeForge, L.E., Tracey, D.E., Kenney, J.S., Remick, D.G. Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopoiysaccharide-stimulated human whole blood. Am J Pathol 1992, 140: 1045-54.
23. Selig, W., Tocker, J. Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs. Eur J Pharmacol 1992, 213: 331-6.
24. Cominelli, F., Nast, C.C., Duchini, A., Lee, M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992, 103: 65-71.
25. Thomas, T.K., Will, P.C., Srivastava, A. et al. Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid induced colitis model. Agents Actions 1991, 34: 187-90.
26. Cominelli, F., Nast, C.C., Clark, B.D. et al. Interleukin-1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990, 86: 972-80.
27. Rosenbaum, J.T., Boney, R.S. Activity of an interieukin-1 receptor antagonist in rabbit models of uveitis. Arch Ophthalmol 1992, 110: 547-9.
28. Xin, L., Blatteis, C.M. Blockade by interleukin-1 receptor antagonist of IL-1β induced neuronal activity in guinea pig preoptic area slices. Brain Res 1992, 569: 348-52.
29. Coceani, F., Lees, J., Redford, J., Bishai, I. Interleukin-1 receptor antagonist: Effectiveness against interleukin-1 fever. Can J Physiol Pharmacol 1992, 70 : 1590-6.
30. McLaughlin, C.L., Rogan, G.J., Tou, J., Baile, C.A., Joy, W.D. Food intake and body temperature responses of rats to recombinant human interleukin-1β and tripeptide interleukin-1β antagonist. Physiol Behav 1992, 52: 1155-60.
31. Smith, B.K., Kluger, M.J. Human IL-1 receptor antagonist partially suppresses LPS fever but not plasma levels of IL-6 in Fischer rats. Am J Physiol 1992, 263: R653-5.
32. Meyers, K.P., Czachowski, C.L., Coffey, J.W. Effect of treatment with interleukin-1 receptor antagonist on the development of carrageenin-induced pleurisy in the rat. Inflammation 1993, 17: 121-34.
33. Voelkel, N.F., Tuder, R. Interleukin-1 receptor antagonist inhibits pulmonary hypertension induced by inflammation. Ann NY Acad Sci 1994, 28: 104-9.
34. Watson, M.L., Smith, D., Boune, A.D., Thompson, R.C., Westwick, J. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: Inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1993, 8: 365-9.
35. Conti, P., Reale, M., Panara, M.R., Fridas, S., Placido, F.C., Barbacane, R.C. Interleukin-1 receptor antagonist inhibits calcium accumulation in in vivo chronic granuloma induced by potassium permanganate. Calcif Tissue Int 1993, 52: 300-4.
36. Conti,P., Panara, M.R., Fridas, S. et al. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrlL-1ra). Cell Immunol 1993, 147: 446-57.
37. Chensue, S.W., Warmington, K.S., Benger, A.E., Tracey, D.E. Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 human lymphoid tissue and granulomas. Am J Pathol 1992, 140: 269-75.
38. Lewthwaite, J., Blake, S.M., Hardingham, T.E., Warden, P.J., Henderson, B. The effect of recombinant human interleukin-1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit. J Rheumatol 1994, 21: 467-72.
39. Hu, D.E., Hori, Y., Presta, M., Gresham, G.A., Fan, T.P. Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies. Inflammation 1994, 18: 45-58.
40. Lan, H.Y., Nikolic-Paterson, D.J., Zarama, M., Vannice, J.L., Atkins, R.C. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int 1993, 43: 479-85.
41. Tam, F.W., Smith, J., Cashman, S.J., Wang, Y., Thompson, E.M., Rees, A.J. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1beta genes in antibody mediated gromerulonephritis. Am J Pathol 1994, 145: 126-36.
42. Baergen, R., Benirschke, K., Ulich, T.R. Cytokine expression in the placenta. The role of IL-1 and IL-1ra expression in chorioamnionitis and parturition. Arch Pathol Lab Med 1994, 118: 52-5.
43. Moldawer, L.L. Interleukin-1, TNFα and their naturally occurring antagonists in sepsis. Blood Purif 1993, 11: 128-33.
44. Rolfe, M.W., Standiford, T.J., Kunkel, S.L. et al. IL-1ra expression in sarcoidosis. Am Rev Respir Dis 1993, 148: 1378-84.
45. 4 generation from human monocyte suspensions stimulated by lipopolysaccharide (LPS). Clin Exp Immunol 1993, 91: 526-31.
46. 4) by recombinant interleukin-1 receptor antagonist (IL-1RA) on human monocytes. Agents Actions Spec No: 1992, C93-5.
47. 2 generation in human monocyte cultures. Cell Immunol 1992, 145: 199-209.
48. Brown, Z., Strieter, R.M., Neild, G.R., Thompson, R.C., Kunkel, S.L., Nestwick, J. IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells. Kidney Int 1992, 42: 95-101.
49. Thompson, R.C., Dripps, D.J., Eisenberg, S.P. Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease. Int J Immunopharmacol 1992, 14: 475-80.
50. Ulich, T.R., Yin, S.M., Guo, K.Z., del Castillo, J., Eisenberg, S.P., Thompson, R.C. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin and IL-1 induced acute inflammation. Am J Pathol 1992, 138: 521-4.
51. Chang, M.S., Xiao, J.G., Chiou, G.C.Y. Prevention of ocular inflammation by matrine, prednisolone, and cyclooxygenase and lipoxygenase inhibitors. Acta Pharmacol Sinica 1991, 12: 121-5.
52. Yao, Q.S., Chiou, G.C.Y. Inhibition of crystallines protein-induced inflammation in rabbit eyes with five phytogenic compounds. Acta Pharmacol Sinica 1993, 14: 13-7.
53. Rohde, B.H., Chiou, G.C.Y. Effects of some phytogenic agents and synthetic compounds on complement-cascade mediated hemolysis. Ophthalmic Res 1994, 26: 116-23.
54. Yao, Q.S., Varma, R.S., Liu, S.X.L., Chiou, G.C.Y. Prevention of lens protein-, endotoxin-, and interleukin-1-induced uveitis with chalcone derivatives. Inflammopharmacology 1994, 2: 401-9.
55. Chiou, G.C.Y, Yao, Q.S., Li, B.H.P. Inhibition of lens protein-, endotoxin, and interleukin-1-induced ocular inflammation with osthole and some other non-steroidal antiinflammatory agents. Inflammopharmacology 1993, 2: 5-13.
56. Chiou, G.C.Y., Yao, Q.S., Varina, R.J. Inhibition of ocular inflammation by chalcone derivatives and prednisolone. J Ocul Pharmacol Ther 1992, 8: 213-23.
57. Xiao, J.G., Chiou, G.C.Y. Tetrandrine inhibits breakdown of blood-aqueous barrier induced by endotoxin and interleukin-1alpha in rats. J Ocul Pharmacol Ther 1996, 12: 323-9.
58. Granowitz, E.V., Porat, R., Mier, J.W. et al. Pharmacokinetics, safety, and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 1992, 4: 353-60.
59. 2 in rabbit blood. Acta Pharmacol Sinica 1993, 14: 325-8.
60. Wong, C.W., Thong, Y.H., Seow, W.K. Comparative effects of tetrandrine and berbamine on guinea pig airway microvascular leakage induced by platelet-activating factor and other allergic mediators. Int J Immunopharmacol 1993, 15: 185-93.
61. Kondo, Y., Takano, F., Hojo, H. Suppression of lipopolysaccharide-induced fulminant hepatitis and tumor necrosis factor production by bisbenzylisoquinoline alkaloids in bacillus Calmette-Guerin-treated mice. Biochem Pharmacol 1993, 46: 1861-3.
62. Ferrante, A., Seow, W.K., Rowan-Kelly, B., Thong, Y.H. Tetrandrine, a plant alkaloid, inhibits the production of tumor necrosis factor-α (cachectin) by human monocytes. Clin Exp Immunol 1990, 8: 232-5.
63. Seow, W.K., Ferrante, A., Summors, A., Thong, Y.H. Comparative effects of tetrandrine and berbamine on production of the inflammatory cytokines interleukin-1 and tumor necrosis factor. Life Sci 1992, 50: PL53-8.
64. Kondo, Y., Takano, F., Hojo, H. Inhibitory effect of bisbenzylisoquinoline alkaloids on nitric oxide production in activated macrophages. Biochem Pharmacol 1993, 46: 1887-92.
65. Matsuno, T., Orita, K., Edashige, K. et al. Inhibition of active oxygen generation in guinea-pig neutrophils by biscoclaurine alkaloids. Biochem Pharmacol 1990, 39: 1255-9.
66. Li, S.Y., Ling, L.H., Teh, B.S., Seow, W.K., Thong, Y.H. Antiinflammatory and immunosupressive properties of the bis-benzylisoquinolines: In vitro comparisons of tetrandrine and berbamine. Int J Immunopharmacol 1989, 11: 395-401.
67. Seow, W.K., Ferrante, A., Li, S.Y., Thong, Y.H. Antiphagocytic and antioxidant properties of plant alkaloid tetrandrine. Int Arch Allergy Appl Immunol 1988, 85: 404-9.
68. He, F.C., Tang, R.Y., Yao, D.F. Effects of tetrandrine on vascular permeability and neutrophil function in acute inflammation. Acta Pharmacol Sinica 1989, 10: 249-51.
69. Teh, B.S., Seow, W.K., Chalmers, A.H., Playford, S., Ioannoni, B., Thong, Y.H. Inhibition of histamine release from rat mast cells by the plant alkaloid tetrandrine. Int Arch Allergy Appl Immunol 1988, 86: 220-4.
70. Nakomura, K., Tsuchigo, S., Sugimoto, Y., Sugimura, Y., Yamada, Y. Histamine release inhibition activity of bisbenzylisoquinoline alkaloids. Planta Med 1992, 58: 505-8.
71. Xiao, J.G., Wang, Y.L., Wu, S.Y., Li, J.G., Zhang, S.P. Inhibitory effect of tetrandrine on lens proteins-induced ocular inflammation in rabbits. J Ocul Pharmacol Ther 1992, 8: 309-15.
72. Xiao, J.G., Wu, S.Y., Wang, Y.L., Li, J.G., Zhang, S.P. Inhibitory effects of tetrandrine on bovine serum albumin-induced uveitis in rabbits. J Ocul Pharmacol Ther 1993, 9: 151-6.
73. Kang, J.H., Lewis, D.M., Castranova, V. et al. Inhibitory action of tetrandrine on macrophage production of interleukin-1 (IL-1) like activity and thymocyte proliferation. Exp Lung Res 1992, 18: 715-29.
74. Seow, W.K., Ferrante, A., Li, S.Y., Thong, Y.H. Suppression of human monocyte interleukin-1 production by the plant alkaloid tetrandrine. Clin Exp Immunol 1989, 75: 47-51.
75. Chang, M.L., Yang, L.L., Chang, D.M., Kuo, S.Y., Chu, S.J. The influence of Chinese traditional medicine on the production and activity of interleukin-1 (IL-1). Chin J Microbiol Immunol 1993, 26: 15-24.
76. Wong, C.W., Seow, W.K., Zeng, T.S., Halliday, W.J., Thong, Y.H. Comparative immunopharmacology and toxicology of the bisbenzylisoquinoline alkaloids tetrandrine and berbamine. Int J Immunol Pharmacol 1991, 13: 579-85.
77. Li, O.L. The therapeutic effect of tetrandrine on silicosis. Chin J Tuberc Dis 1981, 4: 321-3.
78. Chiou, G.C.Y., Liu, S.X.L. Systemic anti-inflammation by synthetic interleukin-1 blockers. Acta Pharmacol Sinca 1999, 20: 405-8.
79. Chiou, G.C.Y., Chen, J.Z., Xuan, B., Yamasaki, T., Okawara, T. Antagonism of interleukin-1 (IL-1) induced uveitis with synthetic IL-1 blockers. J Ocul Pharmacol Ther 1997, 13: 427-33.
80. Xuan, B., Chiou, G.C.Y., Chen, Z., Yamasaki, T., Okawara, T. Effective treatment of experimental uveitis with interleukin-1 blockers, CK 123 and CK 124. J Ocul Pharmacol Ther 1998, 14: 31-44.
81. Xuan, B., Chiou, G.C.Y., Yamasaki, T., Okawara, T. Antiuveitis and inhibition of fibroblast-like corneal and conjunctival cell cultures by interleukin-1 blockers, CK 125, CK 126 and CK 128. Ophthalmic Res 1998, 30: 180-8.
82. Chiou, G.C.Y., Xuan, B., Yamasaki, T., Okawara, T. Anti-inflammation and antifibroblastic actions of interleukin-1 blockers. J Ocul Pharmacol Ther 1998 14: 375-88.
83. Xuan, B., Chiou, G.C.Y. Anti-uveitis and inhibition of fibroblast-like corneal and conjunctival cells by interleukin-1 blockers. Inflammopharmacology 1998, 6: 119-32.
84. Xiao, J.G., Schwade, N., Chiou, G.C.Y. Mechanisms of antagonism of interleukin-1α by synthetic interleukin-1 blockers. J Ocul Pharmacol Ther 1995, 11: 369-78.
85. Schwade, N., Chiou, G.C.Y. The use of trabeculectomy to study the pharmacological modulation of ophthalmic wound healing. J Ocul Pharmacol Ther 1995, 11: 113-24.
86. Schwade, N., Chiou, G.C.Y. Effects of interleukin-1 blockers on ophthalmic wound healing in a rabbit model of trabeculectomy. J Ocul Pharmacol Ther 1995, 11: 125-34.
87. Chen, J.Z., Liu, S.X.L., Chiou, G.C.Y. Inhibitory effects of IL-1 blockers on cornea/ fibroblast proliferation. J Ocul Pharmacol Ther 1996, 12: 169-82.
88. Xuan, B., Chiou, G.C.Y. Inhibition of fibroblast-like cell proliferation by interleukin-1 blockers, CK-119 and CK-122. Acta Pharmacol Sinica 1998, 19: 304-8.
89. Chiou, G.C.Y., Zhou, Y.H., Xuan, B., Yamasaki, T., Okawara, T. Suppression of interleukin-1 a induced uveitis and inhibition of fibroblast-like cell proliferation by synthetic interleukin-1 blockers. J Ocul Pharmacol 1999, 15: 351-62.
90. Wilson, M.R., Lee, D.A., Baker, R.S., Goodwin, L.T., Wooten, F. The effects of topical mitomycin on glaucoma filtration surgery in rabbits. J Ocul Pharmacol Ther 1991, 7: 1-8.
91. Chen, C.W., Huang, H.T., Bair, J.S., Lee, C.C. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol Ther 1990, 6: 175-82.
92. Palmer, S.S. Mitomycin as an adjunct chemotherapy with trabeculectomy. Ophthalmology 1991, 98: 317-21.
93. Bergstrom, T.J., Wilkinson, S., Skuta, G.L., Watnick, R.L., Einer, V.M. The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits. Arch Ophthalmol 1991, 109: 1725-30.